Bradykinin B1/B2 Receptor Agonist

B1R:B2R Agonist

B1B2 Receptor Agonist

Product Description

Product: B1/B2 Receptor Agonist
Sequence: Nalpha-linked B1R/B2R agonist heterodimer
Purity: Over 95%
Application: Metabolically stable dimer agonist for temporary permeabilization of the blood brain barrier and blood tumor barrier
Disciplines: Brain cancer, drug delivery
CAS#: 1698014-08-2
Molecular weight: 2525 Daltons
Chemical structure: Nα-linked B1R:B2R agonist heterodimer


Anticancer Drug Delivery into Brain Tumors

  1. Côté J, Savard M, Neugebauer W, Fortin D, Lepage M, Gobeil F. Dual kinin B1 and B2 receptor activation provides enhanced blood–brain barrier permeability and anticancer drug delivery into brain tumors. Cancer Biology & Therapy. 2013;14(9):806-811.


Transient Opening of Blood-Brain and Blood-Brain Tumor Barriers


Obtain up to 20% discount for your longitudinal in vivo studies. Click here to learn more about our Vision without Sacrifice Campaign.


Bradykinin B1/B2 Receptor Agonist